Global Plaque Psoriasis Treatment Medications Market Outlook, In‑Depth Analysis & Forecast to 2031

1 Study Coverage
1.1 Introduction to Plaque Psoriasis Treatment Medications: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Plaque Psoriasis Treatment Medications Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Biologics
1.2.3 Small Molecule Drugs
1.2.4 Non-biologic Drugs
1.3 Market Segmentation by Application
1.3.1 Global Plaque Psoriasis Treatment Medications Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Plaque Psoriasis Treatment Medications Revenue Estimates and Forecasts 2020-2031
2.2 Global Plaque Psoriasis Treatment Medications Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Plaque Psoriasis Treatment Medications Sales Estimates and Forecasts 2020-2031
2.4 Global Plaque Psoriasis Treatment Medications Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Plaque Psoriasis Treatment Medications Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Plaque Psoriasis Treatment Medications Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Biologics Market Size by Manufacturers
3.5.2 Small Molecule Drugs Market Size by Manufacturers
3.5.3 Non-biologic Drugs Market Size by Manufacturers
3.6 Global Plaque Psoriasis Treatment Medications Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Plaque Psoriasis Treatment Medications Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Plaque Psoriasis Treatment Medications Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Plaque Psoriasis Treatment Medications Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Plaque Psoriasis Treatment Medications Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Plaque Psoriasis Treatment Medications Sales and Revenue by Type (2020-2031)
6.4 North America Plaque Psoriasis Treatment Medications Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Plaque Psoriasis Treatment Medications Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Plaque Psoriasis Treatment Medications Sales and Revenue by Type (2020-2031)
7.4 Europe Plaque Psoriasis Treatment Medications Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Plaque Psoriasis Treatment Medications Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Plaque Psoriasis Treatment Medications Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Plaque Psoriasis Treatment Medications Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Plaque Psoriasis Treatment Medications Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Plaque Psoriasis Treatment Medications Sales and Revenue by Type (2020-2031)
9.4 Central and South America Plaque Psoriasis Treatment Medications Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Plaque Psoriasis Treatment Medications Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Plaque Psoriasis Treatment Medications Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Plaque Psoriasis Treatment Medications Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Plaque Psoriasis Treatment Medications Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Amgen
11.1.1 Amgen Corporation Information
11.1.2 Amgen Business Overview
11.1.3 Amgen Plaque Psoriasis Treatment Medications Product Models, Descriptions and Specifications
11.1.4 Amgen Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Amgen Plaque Psoriasis Treatment Medications Sales by Product in 2024
11.1.6 Amgen Plaque Psoriasis Treatment Medications Sales by Application in 2024
11.1.7 Amgen Plaque Psoriasis Treatment Medications Sales by Geographic Area in 2024
11.1.8 Amgen Plaque Psoriasis Treatment Medications SWOT Analysis
11.1.9 Amgen Recent Developments
11.2 Allergan
11.2.1 Allergan Corporation Information
11.2.2 Allergan Business Overview
11.2.3 Allergan Plaque Psoriasis Treatment Medications Product Models, Descriptions and Specifications
11.2.4 Allergan Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Allergan Plaque Psoriasis Treatment Medications Sales by Product in 2024
11.2.6 Allergan Plaque Psoriasis Treatment Medications Sales by Application in 2024
11.2.7 Allergan Plaque Psoriasis Treatment Medications Sales by Geographic Area in 2024
11.2.8 Allergan Plaque Psoriasis Treatment Medications SWOT Analysis
11.2.9 Allergan Recent Developments
11.3 Dermira
11.3.1 Dermira Corporation Information
11.3.2 Dermira Business Overview
11.3.3 Dermira Plaque Psoriasis Treatment Medications Product Models, Descriptions and Specifications
11.3.4 Dermira Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Dermira Plaque Psoriasis Treatment Medications Sales by Product in 2024
11.3.6 Dermira Plaque Psoriasis Treatment Medications Sales by Application in 2024
11.3.7 Dermira Plaque Psoriasis Treatment Medications Sales by Geographic Area in 2024
11.3.8 Dermira Plaque Psoriasis Treatment Medications SWOT Analysis
11.3.9 Dermira Recent Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Corporation Information
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Plaque Psoriasis Treatment Medications Product Models, Descriptions and Specifications
11.4.4 Eli Lilly Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Eli Lilly Plaque Psoriasis Treatment Medications Sales by Product in 2024
11.4.6 Eli Lilly Plaque Psoriasis Treatment Medications Sales by Application in 2024
11.4.7 Eli Lilly Plaque Psoriasis Treatment Medications Sales by Geographic Area in 2024
11.4.8 Eli Lilly Plaque Psoriasis Treatment Medications SWOT Analysis
11.4.9 Eli Lilly Recent Developments
11.5 Novartis
11.5.1 Novartis Corporation Information
11.5.2 Novartis Business Overview
11.5.3 Novartis Plaque Psoriasis Treatment Medications Product Models, Descriptions and Specifications
11.5.4 Novartis Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Novartis Plaque Psoriasis Treatment Medications Sales by Product in 2024
11.5.6 Novartis Plaque Psoriasis Treatment Medications Sales by Application in 2024
11.5.7 Novartis Plaque Psoriasis Treatment Medications Sales by Geographic Area in 2024
11.5.8 Novartis Plaque Psoriasis Treatment Medications SWOT Analysis
11.5.9 Novartis Recent Developments
11.6 Merck
11.6.1 Merck Corporation Information
11.6.2 Merck Business Overview
11.6.3 Merck Plaque Psoriasis Treatment Medications Product Models, Descriptions and Specifications
11.6.4 Merck Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Merck Recent Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Corporation Information
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Plaque Psoriasis Treatment Medications Product Models, Descriptions and Specifications
11.7.4 Johnson & Johnson Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Johnson & Johnson Recent Developments
11.8 Pfizer
11.8.1 Pfizer Corporation Information
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Plaque Psoriasis Treatment Medications Product Models, Descriptions and Specifications
11.8.4 Pfizer Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Pfizer Recent Developments
11.9 AstraZeneca
11.9.1 AstraZeneca Corporation Information
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Plaque Psoriasis Treatment Medications Product Models, Descriptions and Specifications
11.9.4 AstraZeneca Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 AstraZeneca Recent Developments
11.10 AbbVie
11.10.1 AbbVie Corporation Information
11.10.2 AbbVie Business Overview
11.10.3 AbbVie Plaque Psoriasis Treatment Medications Product Models, Descriptions and Specifications
11.10.4 AbbVie Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 AbbVie Recent Developments
11.11 LEO Pharma
11.11.1 LEO Pharma Corporation Information
11.11.2 LEO Pharma Business Overview
11.11.3 LEO Pharma Plaque Psoriasis Treatment Medications Product Models, Descriptions and Specifications
11.11.4 LEO Pharma Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 LEO Pharma Recent Developments
11.12 Biogen
11.12.1 Biogen Corporation Information
11.12.2 Biogen Business Overview
11.12.3 Biogen Plaque Psoriasis Treatment Medications Product Models, Descriptions and Specifications
11.12.4 Biogen Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Biogen Recent Developments
11.13 Galectin Therapeutics
11.13.1 Galectin Therapeutics Corporation Information
11.13.2 Galectin Therapeutics Business Overview
11.13.3 Galectin Therapeutics Plaque Psoriasis Treatment Medications Product Models, Descriptions and Specifications
11.13.4 Galectin Therapeutics Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Galectin Therapeutics Recent Developments
11.14 Cellceutix
11.14.1 Cellceutix Corporation Information
11.14.2 Cellceutix Business Overview
11.14.3 Cellceutix Plaque Psoriasis Treatment Medications Product Models, Descriptions and Specifications
11.14.4 Cellceutix Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Cellceutix Recent Developments
11.15 Bayer
11.15.1 Bayer Corporation Information
11.15.2 Bayer Business Overview
11.15.3 Bayer Plaque Psoriasis Treatment Medications Product Models, Descriptions and Specifications
11.15.4 Bayer Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Bayer Recent Developments
11.16 Organon
11.16.1 Organon Corporation Information
11.16.2 Organon Business Overview
11.16.3 Organon Plaque Psoriasis Treatment Medications Product Models, Descriptions and Specifications
11.16.4 Organon Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 Organon Recent Developments
11.17 UCB
11.17.1 UCB Corporation Information
11.17.2 UCB Business Overview
11.17.3 UCB Plaque Psoriasis Treatment Medications Product Models, Descriptions and Specifications
11.17.4 UCB Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 UCB Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Plaque Psoriasis Treatment Medications Industry Chain
12.2 Plaque Psoriasis Treatment Medications Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Plaque Psoriasis Treatment Medications Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Plaque Psoriasis Treatment Medications Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Plaque Psoriasis Treatment Medications Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Plaque Psoriasis Treatment Medications Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

List of Tables
Table 1. Global Plaque Psoriasis Treatment Medications Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Plaque Psoriasis Treatment Medications Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Plaque Psoriasis Treatment Medications Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Plaque Psoriasis Treatment Medications Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Plaque Psoriasis Treatment Medications Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Plaque Psoriasis Treatment Medications Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Plaque Psoriasis Treatment Medications Sales by Region (2020-2025) & (K Units)
Table 8. Global Plaque Psoriasis Treatment Medications Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Plaque Psoriasis Treatment Medications Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Plaque Psoriasis Treatment Medications Sales Share by Manufacturers (2020-2025)
Table 12. Global Plaque Psoriasis Treatment Medications Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Plaque Psoriasis Treatment Medications by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plaque Psoriasis Treatment Medications as of 2024)
Table 16. Global Plaque Psoriasis Treatment Medications Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Plaque Psoriasis Treatment Medications Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Plaque Psoriasis Treatment Medications Manufacturing Base and Headquarters
Table 19. Global Plaque Psoriasis Treatment Medications Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Plaque Psoriasis Treatment Medications Sales by Type (2020-2025) & (K Units)
Table 23. Global Plaque Psoriasis Treatment Medications Sales by Type (2026-2031) & (K Units)
Table 24. Global Plaque Psoriasis Treatment Medications Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Plaque Psoriasis Treatment Medications Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Plaque Psoriasis Treatment Medications ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Plaque Psoriasis Treatment Medications Sales by Application (2020-2025) & (K Units)
Table 29. Global Plaque Psoriasis Treatment Medications Sales by Application (2026-2031) & (K Units)
Table 30. Plaque Psoriasis Treatment Medications High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Plaque Psoriasis Treatment Medications Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Plaque Psoriasis Treatment Medications Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Plaque Psoriasis Treatment Medications ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Plaque Psoriasis Treatment Medications Growth Accelerators and Market Barriers
Table 37. North America Plaque Psoriasis Treatment Medications Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Plaque Psoriasis Treatment Medications Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Plaque Psoriasis Treatment Medications Growth Accelerators and Market Barriers
Table 40. Europe Plaque Psoriasis Treatment Medications Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Plaque Psoriasis Treatment Medications Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Plaque Psoriasis Treatment Medications Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Plaque Psoriasis Treatment Medications Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Plaque Psoriasis Treatment Medications Growth Accelerators and Market Barriers
Table 45. Southeast Asia Plaque Psoriasis Treatment Medications Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Plaque Psoriasis Treatment Medications Investment Opportunities and Key Challenges
Table 47. Central and South America Plaque Psoriasis Treatment Medications Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Plaque Psoriasis Treatment Medications Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Plaque Psoriasis Treatment Medications Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Amgen Corporation Information
Table 51. Amgen Description and Major Businesses
Table 52. Amgen Product Models, Descriptions and Specifications
Table 53. Amgen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Amgen Sales Value Proportion by Product in 2024
Table 55. Amgen Sales Value Proportion by Application in 2024
Table 56. Amgen Sales Value Proportion by Geographic Area in 2024
Table 57. Amgen Plaque Psoriasis Treatment Medications SWOT Analysis
Table 58. Amgen Recent Developments
Table 59. Allergan Corporation Information
Table 60. Allergan Description and Major Businesses
Table 61. Allergan Product Models, Descriptions and Specifications
Table 62. Allergan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Allergan Sales Value Proportion by Product in 2024
Table 64. Allergan Sales Value Proportion by Application in 2024
Table 65. Allergan Sales Value Proportion by Geographic Area in 2024
Table 66. Allergan Plaque Psoriasis Treatment Medications SWOT Analysis
Table 67. Allergan Recent Developments
Table 68. Dermira Corporation Information
Table 69. Dermira Description and Major Businesses
Table 70. Dermira Product Models, Descriptions and Specifications
Table 71. Dermira Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Dermira Sales Value Proportion by Product in 2024
Table 73. Dermira Sales Value Proportion by Application in 2024
Table 74. Dermira Sales Value Proportion by Geographic Area in 2024
Table 75. Dermira Plaque Psoriasis Treatment Medications SWOT Analysis
Table 76. Dermira Recent Developments
Table 77. Eli Lilly Corporation Information
Table 78. Eli Lilly Description and Major Businesses
Table 79. Eli Lilly Product Models, Descriptions and Specifications
Table 80. Eli Lilly Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Eli Lilly Sales Value Proportion by Product in 2024
Table 82. Eli Lilly Sales Value Proportion by Application in 2024
Table 83. Eli Lilly Sales Value Proportion by Geographic Area in 2024
Table 84. Eli Lilly Plaque Psoriasis Treatment Medications SWOT Analysis
Table 85. Eli Lilly Recent Developments
Table 86. Novartis Corporation Information
Table 87. Novartis Description and Major Businesses
Table 88. Novartis Product Models, Descriptions and Specifications
Table 89. Novartis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Novartis Sales Value Proportion by Product in 2024
Table 91. Novartis Sales Value Proportion by Application in 2024
Table 92. Novartis Sales Value Proportion by Geographic Area in 2024
Table 93. Novartis Plaque Psoriasis Treatment Medications SWOT Analysis
Table 94. Novartis Recent Developments
Table 95. Merck Corporation Information
Table 96. Merck Description and Major Businesses
Table 97. Merck Product Models, Descriptions and Specifications
Table 98. Merck Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Merck Recent Developments
Table 100. Johnson & Johnson Corporation Information
Table 101. Johnson & Johnson Description and Major Businesses
Table 102. Johnson & Johnson Product Models, Descriptions and Specifications
Table 103. Johnson & Johnson Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Johnson & Johnson Recent Developments
Table 105. Pfizer Corporation Information
Table 106. Pfizer Description and Major Businesses
Table 107. Pfizer Product Models, Descriptions and Specifications
Table 108. Pfizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Pfizer Recent Developments
Table 110. AstraZeneca Corporation Information
Table 111. AstraZeneca Description and Major Businesses
Table 112. AstraZeneca Product Models, Descriptions and Specifications
Table 113. AstraZeneca Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. AstraZeneca Recent Developments
Table 115. AbbVie Corporation Information
Table 116. AbbVie Description and Major Businesses
Table 117. AbbVie Product Models, Descriptions and Specifications
Table 118. AbbVie Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. AbbVie Recent Developments
Table 120. LEO Pharma Corporation Information
Table 121. LEO Pharma Description and Major Businesses
Table 122. LEO Pharma Product Models, Descriptions and Specifications
Table 123. LEO Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. LEO Pharma Recent Developments
Table 125. Biogen Corporation Information
Table 126. Biogen Description and Major Businesses
Table 127. Biogen Product Models, Descriptions and Specifications
Table 128. Biogen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Biogen Recent Developments
Table 130. Galectin Therapeutics Corporation Information
Table 131. Galectin Therapeutics Description and Major Businesses
Table 132. Galectin Therapeutics Product Models, Descriptions and Specifications
Table 133. Galectin Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Galectin Therapeutics Recent Developments
Table 135. Cellceutix Corporation Information
Table 136. Cellceutix Description and Major Businesses
Table 137. Cellceutix Product Models, Descriptions and Specifications
Table 138. Cellceutix Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Cellceutix Recent Developments
Table 140. Bayer Corporation Information
Table 141. Bayer Description and Major Businesses
Table 142. Bayer Product Models, Descriptions and Specifications
Table 143. Bayer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. Bayer Recent Developments
Table 145. Organon Corporation Information
Table 146. Organon Description and Major Businesses
Table 147. Organon Product Models, Descriptions and Specifications
Table 148. Organon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 149. Organon Recent Developments
Table 150. UCB Corporation Information
Table 151. UCB Description and Major Businesses
Table 152. UCB Product Models, Descriptions and Specifications
Table 153. UCB Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 154. UCB Recent Developments
Table 155. Key Raw Materials Distribution
Table 156. Raw Materials Key Suppliers
Table 157. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 158. Milestones in Production Technology Evolution
Table 159. Distributors List
Table 160. Market Trends and Market Evolution
Table 161. Market Drivers and Opportunities
Table 162. Market Challenges, Risks, and Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources


List of Figures
Figure 1. Plaque Psoriasis Treatment Medications Product Picture
Figure 2. Global Plaque Psoriasis Treatment Medications Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Biologics Product Picture
Figure 4. Small Molecule Drugs Product Picture
Figure 5. Non-biologic Drugs Product Picture
Figure 6. Global Plaque Psoriasis Treatment Medications Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Other
Figure 10. Plaque Psoriasis Treatment Medications Report Years Considered
Figure 11. Global Plaque Psoriasis Treatment Medications Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Plaque Psoriasis Treatment Medications Revenue (2020-2031) & (US$ Million)
Figure 13. Global Plaque Psoriasis Treatment Medications Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Region (2020-2031)
Figure 15. Global Plaque Psoriasis Treatment Medications Sales (2020-2031) & (K Units)
Figure 16. Global Plaque Psoriasis Treatment Medications Sales (CAGR) by Region (2020-2031) (K Units)
Figure 17. Global Plaque Psoriasis Treatment Medications Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Plaque Psoriasis Treatment Medications Sales Volume Market Share in 2024
Figure 19. Global Plaque Psoriasis Treatment Medications Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Biologics Revenue Market Share by Manufacturer in 2024
Figure 22. Small Molecule Drugs Revenue Market Share by Manufacturer in 2024
Figure 23. Non-biologic Drugs Revenue Market Share by Manufacturer in 2024
Figure 24. Global Plaque Psoriasis Treatment Medications Sales Market Share by Type (2020-2031)
Figure 25. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Type (2020-2031)
Figure 26. Global Plaque Psoriasis Treatment Medications Sales Market Share by Application (2020-2031)
Figure 27. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Application (2020-2031)
Figure 28. North America Plaque Psoriasis Treatment Medications Sales YoY (2020-2031) & (K Units)
Figure 29. North America Plaque Psoriasis Treatment Medications Revenue YoY (2020-2031) & (US$ Million)
Figure 30. North America Top 5 Manufacturers Plaque Psoriasis Treatment Medications Sales Revenue (US$ Million) in 2024
Figure 31. North America Plaque Psoriasis Treatment Medications Sales Volume (K Units) by Type (2020- 2031)
Figure 32. North America Plaque Psoriasis Treatment Medications Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 33. North America Plaque Psoriasis Treatment Medications Sales Volume (K Units) by Application (2020-2031)
Figure 34. North America Plaque Psoriasis Treatment Medications Sales Revenue (US$ Million) by Application (2020-2031)
Figure 35. US Plaque Psoriasis Treatment Medications Revenue (2020-2031) & (US$ Million)
Figure 36. Canada Plaque Psoriasis Treatment Medications Revenue (2020-2031) & (US$ Million)
Figure 37. Mexico Plaque Psoriasis Treatment Medications Revenue (2020-2031) & (US$ Million)
Figure 38. Europe Plaque Psoriasis Treatment Medications Sales YoY (2020-2031) & (K Units)
Figure 39. Europe Plaque Psoriasis Treatment Medications Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Europe Top 5 Manufacturers Plaque Psoriasis Treatment Medications Sales Revenue (US$ Million) in 2024
Figure 41. Europe Plaque Psoriasis Treatment Medications Sales Volume (K Units) by Type (2020-2031)
Figure 42. Europe Plaque Psoriasis Treatment Medications Sales Revenue (US$ Million) by Type (2020-2031)
Figure 43. Europe Plaque Psoriasis Treatment Medications Sales Volume (K Units) by Application (2020-2031)
Figure 44. Europe Plaque Psoriasis Treatment Medications Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. Germany Plaque Psoriasis Treatment Medications Revenue (2020-2031) & (US$ Million)
Figure 46. France Plaque Psoriasis Treatment Medications Revenue (2020-2031) & (US$ Million)
Figure 47. U.K. Plaque Psoriasis Treatment Medications Revenue (2020-2031) & (US$ Million)
Figure 48. Italy Plaque Psoriasis Treatment Medications Revenue (2020-2031) & (US$ Million)
Figure 49. Russia Plaque Psoriasis Treatment Medications Revenue (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Plaque Psoriasis Treatment Medications Sales YoY (2020-2031) & (K Units)
Figure 51. Asia-Pacific Plaque Psoriasis Treatment Medications Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Top 8 Manufacturers Plaque Psoriasis Treatment Medications Sales Revenue (US$ Million) in 2024
Figure 53. Asia-Pacific Plaque Psoriasis Treatment Medications Sales Volume (K Units) by Type (2020- 2031)
Figure 54. Asia-Pacific Plaque Psoriasis Treatment Medications Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 55. Asia-Pacific Plaque Psoriasis Treatment Medications Sales Volume (K Units) by Application (2020-2031)
Figure 56. Asia-Pacific Plaque Psoriasis Treatment Medications Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Indonesia Plaque Psoriasis Treatment Medications Revenue (2020-2031) & (US$ Million)
Figure 58. Japan Plaque Psoriasis Treatment Medications Revenue (2020-2031) & (US$ Million)
Figure 59. South Korea Plaque Psoriasis Treatment Medications Revenue (2020-2031) & (US$ Million)
Figure 60. China Taiwan Plaque Psoriasis Treatment Medications Revenue (2020-2031) & (US$ Million)
Figure 61. India Plaque Psoriasis Treatment Medications Revenue (2020-2031) & (US$ Million)
Figure 62. Central and South America Plaque Psoriasis Treatment Medications Sales YoY (2020-2031) & (K Units)
Figure 63. Central and South America Plaque Psoriasis Treatment Medications Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Central and South America Top 5 Manufacturers Plaque Psoriasis Treatment Medications Sales Revenue (US$ Million) in 2024
Figure 65. Central and South America Plaque Psoriasis Treatment Medications Sales Volume (K Units) by Type (2021-2031)
Figure 66. Central and South America Plaque Psoriasis Treatment Medications Sales Revenue (US$ Million) by Type (2020-2031)
Figure 67. Central and South America Plaque Psoriasis Treatment Medications Sales Volume (K Units) by Application (2020-2031)
Figure 68. Central and South America Plaque Psoriasis Treatment Medications Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Brazil Plaque Psoriasis Treatment Medications Revenue (2020-2025) & (US$ Million)
Figure 70. Argentina Plaque Psoriasis Treatment Medications Revenue (2020-2025) & (US$ Million)
Figure 71. Middle East, and Africa Plaque Psoriasis Treatment Medications Sales YoY (2020-2031) & (K Units)
Figure 72. Middle East and Africa Plaque Psoriasis Treatment Medications Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Middle East and Africa Top 5 Manufacturers Plaque Psoriasis Treatment Medications Sales Revenue (US$ Million) in 2024
Figure 74. Middle East and Africa Plaque Psoriasis Treatment Medications Sales Volume (K Units) by Type (2021-2031)
Figure 75. South America Plaque Psoriasis Treatment Medications Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Middle East and Africa Plaque Psoriasis Treatment Medications Sales Volume (K Units) by Application (2020-2031)
Figure 77. Middle East and Africa Plaque Psoriasis Treatment Medications Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. GCC Countries Plaque Psoriasis Treatment Medications Revenue (2020-2025) & (US$ Million)
Figure 79. Turkey Plaque Psoriasis Treatment Medications Revenue (2020-2025) & (US$ Million)
Figure 80. Egypt Plaque Psoriasis Treatment Medications Revenue (2020-2025) & (US$ Million)
Figure 81. South Africa Plaque Psoriasis Treatment Medications Revenue (2020-2025) & (US$ Million)
Figure 82. Plaque Psoriasis Treatment Medications Industry Chain Mapping
Figure 83. Regional Plaque Psoriasis Treatment Medications Manufacturing Base Distribution (%)
Figure 84. Global Plaque Psoriasis Treatment Medications Production Market Share by Region (2020-2031)
Figure 85. Plaque Psoriasis Treatment Medications Production Process
Figure 86. Regional Plaque Psoriasis Treatment Medications Production Cost Structure
Figure 87. Channels of Distribution (Direct Vs Distribution)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit